Literature DB >> 7741741

PTH and 1,25(OH)2 vitamin D priming to growth factors differentially regulates the osteoblastic markers in MBA-15 clonal subpopulations.

D Benayahu1, A Fried, S Wientroub.   

Abstract

The functional modulation of enzymatic activities of alkaline phosphatase (ALK-P) and neutral endopeptidase (CD10/NEP) in MBA-15.4 and MBA-15.6 marrow stromal osteoblastic cells was studied. The hormonal effects of parathyroid hormone (PTH) and 1,25 (OH)2D3 combined with various growth factors (bone morphogenic protein [BMP-2 and BMP-3], TGF beta and IGF-I) on these cells were monitored. The cell responses of MBA-15.4, a preosteoblastic cell, and MBA-15.6, a more mature osteoblastic cell, to the growth factors and the hormonal challenge were measured by changes of the enzymatic activities (ALK-P and CD10/NEP). The cellular response was not uniform and revealed a differential pattern.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7741741     DOI: 10.1006/bbrc.1995.1646

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.

Authors:  David J Mahoney; Katalin Mikecz; Tariq Ali; Guillaume Mabilleau; Dafna Benayahu; Anna Plaas; Caroline M Milner; Anthony J Day; Afsaneh Sabokbar
Journal:  J Biol Chem       Date:  2008-06-26       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.